L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells

Cancer Letters

Volumn 239, Issue 2, 2006, Pages 212-226

  Stoeck, Alexander ^a   Schlich, Sabine ^a   Issa, Yasmin ^a   Gschwend, Verena ^a   Wenger, Till ^a   Herr, Ingrid ^a   Marmé, Alexander ^b   Bourbie, Sarah ^c   Altevogt, Peter ^a   Gutwein, Paul ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c INSTITUT COCHIN   (France)

Author keywords

Cell adhesion; Heterophilic binding; L1 adhesion molecule; Mesothelial cells; Neuropilin 1

Indexed keywords

BIOLOGICAL MARKER; HYBRID PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE L1; NEUROPILIN 1;

ARTICLE; ASCITES FLUID; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; CARCINOGENESIS; CARCINOMA CELL; CELL ACTIVITY; CELL ISOLATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MESOTHELIUM CELL; OVARY CARCINOMA; PERITONEUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOLUBILITY;

BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; HUMANS; MICROSCOPY, FLUORESCENCE; NEURAL CELL ADHESION MOLECULE L1; NEUROPILIN-1; OVARIAN NEOPLASMS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33745639466     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.08.005     Document Type: Article

References (55)

1. Jensen O.M., Esteve J., Moller H., and Renard H. Cancer in the European Community and its member states. Eur. J. Cancer 26 (1990) 1167-1256
2. Auersperg N., Wong A.S., Choi K.C., Kang S.K., and Leung P.C. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22 (2001) 255-288
3. Kikkawa F., Ishikawa H., Tamakoshi K., Suganuma N., Mizuno K., Kawai M., et al. Prognostic evaluation of lymphadenectomy for epithelial ovarian cancer. J. Surg. Oncol. 60 (1995) 227-231
4. Milliken D., Scotton C., Raju S., Balkwill F., and Wilson J. Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites. Clin. Cancer Res. 8 (2002) 1108-1114
5. Fogel M., Gutwein P., Mechtersheimer S., Riedle S., Stoeck A., Smirnov A., et al. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362 (2003) 869-875
6. Brummendorf T., Wolff J.M., Frank R., and Rathjen F.G. Neural cell recognition molecule F11: homology with fibronectin type III and immunoglobulin type C domains. Neuron 2 (1989) 1351-1361
7. Moos M., Tacke R., Scherer H., Teplow D., Fruh K., and Schachner M. Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. Nature 334 (1988) 701-703
8. Schachner M. Neural recognition molecules and synaptic plasticity. Curr. Opin. Cell Biol. 9 (1997) 627-634
9. Castellani V., De Angelis E., Kenwrick S., and Rougon G. Cis and trans interactions of L1 with neuropilin-1 control axonal responses to semaphorin 3A. Eur. Mol. Biol. Org. L J. 21 (2002) 6348-6357
10. Itoh K., Cheng L., Kamei Y., Fushiki S., Kamiguchi H., Gutwein P., et al. Brain development in mice lacking L1-L1 homophilic adhesion. J. Cell Biol. 165 (2004) 145-154
11. He Z., and Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90 (1997) 739-751
12. Kolodkin A.L., Levengood D.V., Rowe E.G., Tai Y.T., Giger R.J., and Ginty D.D. Neuropilin is a semaphorin III receptor. Cell 90 (1997) 753-762
13. Kawasaki T., Kitsukawa T., Bekku Y., Matsuda Y., Sanbo M., Yagi T., and Fujisawa H. A requirement for neuropilin-1 in embryonic vessel formation. Development 126 (1999) 4895-4902
14. Kitsukawa T., Shimono A., Kawakami A., Kondoh H., and Fujisawa H. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 121 (1995) 4309-4318
15. Stephenson J.M., Banerjee S., Saxena N.K., Cherian R., Cherian R., and Banerjee S.K. Neuropilin-1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: a possible marker for the progression of breast cancer. Int. J. Cancer 101 (2002) 409-414
16. Latil A., Bieche I., Pesche S., Valeri A., Fournier G., Cussenot O., and Lidereau R. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int. J. Cancer 89 (2000) 167-171
17. Parikh A.A., Fan F., Liu W.B., Ahmad S.A., Stoeltzing O., Reinmuth N., et al. Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am. J. Pathol. 164 (2004) 2139-2151
18. Miao H.Q., Lee P., Lin H., Soker S., and Klagsbrun M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. Fed. Am. Soc. Exp. Biol. J. 14 (2000) 2532-2539
19. Soker S., Takashima S., Miao H.Q., Neufeld G., and Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92 (1998) 735-745
20. Gast D., Riedle S., Riedle S., Schabath H., Schlich S., Schneider A., et al. L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int. J. Cancer 115 (2005) 658-665
21. Mechtersheimer S., Gutwein P., Agmon-Levin N., Stoeck A., Oleszewski M., Riedle S., et al. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J. Cell Biol. 155 (2001) 661-673
22. Ebeling O., Duczmal A., Aigner S., Geiger C., Schollhammer S., Kemshead J.T., et al. L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin. Eur. J. Immunol. 26 (1996) 2508-2516
23. Rossignol M., Gagnon M.L., and Klagsbrun M. Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics 70 (2000) 211-222
24. Kowitz A., Kadmon G., Eckert M., Schirrmacher V., Schachner M., and Altevogt P. Expression and function of the neural cell adhesion molecule L1 in mouse leukocytes. Eur. J. Immunol. 22 (1992) 1199-1205
25. Cannistra S.A., Kansas G.S., Niloff J., DeFranzo B., Kim Y., and Ottensmeier C. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res. 53 (1993) 3830-3838
26. Bachelder R.E., Crago A., Chung J., Wendt M.A., Shaw L.M., Robinson G., and Mercurio A.M. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res. 61 (2001) 5736-5740
27. Lacal P.M., Failla C.M., Pagani E., Odorisio T., Schietroma C., Falcinelli S., et al. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J. Invest Dermatol. 115 (2000) 1000-1007
28. Fakhari M., Pullirsch D., Abraham D., Paya K., Hofbauer R., Holzfeind P., et al. Selective upregulation of vascular endothelial growth factor receptors neuropilin-1 and -2 in human neuroblastoma. Cancer 94 (2002) 258-263
29. Xiang W., Wimberger P., Dreier T., Diebold J., Mayr D., Baeuerle P.A., and Kimmig R. Cytotoxic activity of novel human monoclonal antibody MT201 against primary ovarian tumor cells. J. Cancer Res. Clin. Oncol. 129 (2003) 341-348
30. Friedlander M.L., and Dembo A.J. Prognostic factors in ovarian cancer. Semin. Oncol. 18 (1991) 205-212
31. Felding-Habermann B., Silletti S., Mei F., Siu C.H., Yip P.M., Brooks P.C., et al. A single immunoglobulin-like domain of the human neural cell adhesion molecule L1 supports adhesion by multiple vascular and platelet integrins. J. Cell Biol. 139 (1997) 1567-1581
32. Kadmon G., and Altevogt P. The cell adhesion molecule L1: species- and cell-type-dependent multiple binding mechanisms. Differentiation 61 (1997) 143-150
33. Montgomery A.M., Becker J.C., Siu C.H., Lemmon V.P., Cheresh D.A., Pancook J.D., et al. Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3. J. Cell Biol. 132 (1996) 475-485
34. Silletti S., Mei F., Sheppard D., and Montgomery A.M. Plasmin-sensitive dibasic sequences in the third fibronectin-like domain of L1-cell adhesion molecule (CAM) facilitate homomultimerization and concomitant integrin recruitment,. J. Cell Biol. 149 (2000) 1485-1502
35. Oleszewski M., Beer S., Katich S., Geiger C., Zeller Y., Rauch U., and Altevogt P. Integrin and neurocan binding to L1 involves distinct Ig domains. J. Biol. Chem. 274 (1999) 24602-24610
36. Lemmon V., Farr K.L., and Lagenaur C. L1-mediated axon outgrowth occurs via a homophilic binding mechanism. Neuron 2 (1989) 1597-1603
37. Gutwein P., Stoeck A., Riedle S., Gast D., Runz S., Condon T.P., et al. Cleavage of l1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin. Cancer Res. 11 (2005) 2492-2501
38. Silletti S., Yebra M., Perez B., Cirulli V., McMahon M., and Montgomery A.M. Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J. Biol. Chem. 279 (2004) 28880-28888
39. Bachelder R.E., Lipscomb E.A., Lin X., Wendt M.A., Chadborn N.H., Eickholt B.J., and Mercurio A.M. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res. 63 (2003) 5230-5233
40. Thijssen V.L., Brandwijk R.J., Dings R.P., and Griffioen A.W. Angiogenesis gene expression profiling in xenograft models to study cellular interactions. Exp. Cell Res. 299 (2004) 286-293
41. Gray M.J., and Wey J.S. A. Belcheva. M.F. McCarty, J.G. Trevino, D.B.Evans, L.M. Ellis, G.E Gallick, Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors, Cancer Res. 65 (2005) 3664-3670
42. Kikkawa F., Kajiyama H., Ino K., Shibata K., and Mizutani S. Adhesion potency to mesothelial cells by overexpression of dipeptidyl peptidase IV. Adv. Exp. Med. Biol. 524 (2003) 249-252
43. Rump A., Morikawa Y., Tanaka M., Minami S., Umesaki N., Takeuchi M., and Miyajima A. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J. Biol. Chem. 279 (2004) 9190-9198
44. Casey R.C., Oegema Jr. T.R., Skubitz K.M., Pambuccian S.E., Grindle S.M., and Skubitz A.P. Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells. Clin. Exp. Metastasis 20 (2003) 143-152
45. Hubbe M., Kowitz A., Schirrmacher V., Schachner M., and Altevogt P. L1 adhesion molecule on mouse leukocytes: regulation and involvement in endothelial cell binding. Eur. J. Immunol. 23 (1993) 2927-2931
46. Naora H., and Montell D.J. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat. Rev. Cancer 5 (2005) 355-366
47. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
48. Murga M., Fernandez-Capetillo O., and Tosato G. Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood 105 (2005) 1992-1999
49. Zebrowski B.K., Liu W., Ramirez K., Akagi Y., Mills G.B., and Ellis L.M. Markedly elevated levels of vascular endothelial growth factor in malignant ascites. Ann. Surg. Oncol. 6 (1999) 373-378
50. Sowter H.M., Corps A.N., Evans A.L., Clark D.E., Charnock-Jones D.S., and Smith S.K. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. Lab. Invest. 77 (1997) 607-614
51. Barton D.P., Cai A., Wendt K., Young M., Gamero A., and De Cesare S. Angiogenic protein expression in advanced epithelial ovarian cancer. Clin. Cancer Res. 3 (1997) 1579-1586
52. Gadducci A., Ferdeghini M., Fanucchi A., Annicchiarico C., Ciampi B., Prontera C., and Genazzani A.R. Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome. Anticancer Res. 19 (1999) 1401-1405
53. Oehler M.K., and Caffier H. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer. Anticancer Res. 20 (2000) 5109-5112
54. Kraft A., Weindel K., Ochs A., Marth C., Zmija J., Schumacher P., et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 85 (1999) 178-187
55. Hall H., and Hubbell J.A. Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2. Microvasc. Res. 68 (2004) 169-178